A bioelectromagnetic hypothesis of chronic primary pain: from thalamocortical dysrhythmia to the consciousness-brain interface - Scorecard - MDSpire

A bioelectromagnetic hypothesis of chronic primary pain: from thalamocortical dysrhythmia to the consciousness-brain interface

  • By

  • Muhammad Khatib

  • Dror Robinson

  • Mustafa Yassin

  • June 4, 2026

  • 0 min

Share

Clinical Scorecard: A Bioelectromagnetic Perspective on Chronic Primary Pain: Exploring the Link Between Thalamocortical Dysrhythmia and the Consciousness-Brain Connection

At a Glance

CategoryDetail
Condition
Key MechanismsDisruption of bioelectromagnetic coherence at the interface of consciousness and neural tissue (source needed).
Target Population
Care Setting

Key Highlights

  • Chronic primary pain is recognized as a disease in ICD-11.
  • Thalamocortical dysrhythmia linked to chronic pain documented via magnetoencephalography.
  • Heart rate variability abnormalities found in chronic pain populations.
  • Photobiomodulation shows efficacy in treating chronic pain (source needed).

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider novel therapeutic approaches targeting electromagnetic coherence restoration (source needed).

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Approximately 20% of the global adult population affected by chronic pain.

        Current treatments are often inadequate, necessitating exploration of bioelectromagnetic approaches.

        Clinical Best Practices

        • Utilize magnetoencephalography to assess thalamocortical dysrhythmia.
        • Monitor heart rate variability in chronic pain patients.

        Related Resources & Content

        Original Source(s)

        A bioelectromagnetic hypothesis of chronic primary pain: from thalamocortical dysrhythmia to the consciousness-brain interface

        • by Muhammad Khatib, Dror Robinson, Mustafa Yassin

        • June 4, 2026

        Related Content

        PT vs CBT for Chronic Low Back Pain

        Sequential, multiple-assignment randomized trial compares stage I and stage II nonpharmacologic treatments over 52 weeks.

        Integrating multi-omics and machine learning to explore the role of amino acid metabolism in intervertebral disk degeneration

        Medical Oddities: From Romance to Recall Issues

        Mental health check: what patients eat, watch, love, and dream may all be in play